Indeed, urea cycle dysregulated cancers, with functional loss of ASS1, have been linked to favourable genetic and biochemical signatures associated with increased responsiveness to immune checkpoint blockade (Lee et al., 2018). This evidence concerns the gene ASS1 and cancer.